Unlocking the Secrets of NAD in Health and Longevity
NAD is found in all living cells and is essential for converting food into energy. It operates as a coenzyme in redox reactions, playing a…
Pharma
Priory Signs a New Five-year Agreement with Ashtons
The UK’s largest independent provider of mental health services will benefit from medicines supply and pharmacy services alongside further development of the newly implemented e-Works…
Transforming Rebate Contract Management in Pharmaceuticals: The AI Advantage
In the pharmaceutical industry, many rebate contract managers spend hundreds of hours manually identifying key data points from thousands of contracts. Rebate contracts can impact…
Early, Built-in GxP System Validation: A Critical Determinant of Project Success
As Life Sciences companies comes to rely increasingly on digital capabilities and good data for efficiency and competitive advantage, it’s critical that they harness system…
Generative AI in Action in Life Sciences: Transforming Adverse Event Case Intake
Adverse event (AE) case intake in Life Sciences is crying out for disruption by AI. And now, at last, Generative AI and Large Language Models…
Could GenAI Revolutionise Pharma Medical Writing?
Medical writing in pharma is ripe for disruption, across use cases linked to regulatory documentation and safety report summaries, and Generative AI (GenAI) promises exactly…
Patients Are Waiting: Speeding Time to Treatment in Rare Disease
Companies are overcoming challenges to develop, launch, and educate on new rare disease medicines and treatment faster. Rare diseases are no longer rare. Every year,…
How IT can Deliver the Time and Support that Pharmacy needs to Deliver New Services
Pharmacy First could pave the way for pharmacy to become the backbone of primary care in England – but pharmacists will need investment and support…
What’s the State of AI-enabled Automation in Pharma R&D?
Smart automation promises to transform life sciences research and development operations, and streamline pharma companies’ path to market while enhancing patient safety. But how far…
Novel Drugs: The Case for Applied Behavioural Science in Driving Take up
Behavioural science’s time has come in the pharma industry, as medical communications adapt to a more ambitious and diverse treatment landscape. Here, Alpharmaxim’s William Hind…